STRONG SCIENTIFIC PARTNERS

CARDIOMEDEX

As a subsidiary of Physiogenex, Cardiomedex shares the same management and facilities, and co-develops innovative in vivo models of cardiometabolism and preclinical services.

Cardiomedex provides expertise in cardiovascular diseases, oncocardiology and neurocardiology to evaluate the cardiovascular effects of drug candidates: myocardial infarction, cardiac arrhythmia, cardiac hypertrophy, heart failure, hypertension, and cardiotoxicity. Cardiomedex services can be applied to Physiogenex’s models providing a complete evaluation of customers' drugs on cardiometabolic disorders.

Visit the Cardiomedex website for more information.

JANVIER GROUP

Since its origins in 1960, Janvier Group has evolved into an essential partner in Drug Discovery & Preclinical Research, providing more than 3500 clients worldwide with a unique combination of models and innovative solutions. They leverage the latest technologies to deliver well-characterized in vitro, in vivo, and custom-created models, as well as a range of tailored services to support research from hit identification to candidate selection, with strong expertise in understanding mechanisms of action. Janvier Group operates internationally with a team of over 600 dedicated experts.

Visit the Janvier Group website for more information.

CLEA Japan, Inc

Since 1965, CLEA Japan, Inc. is an independent company producing SPF animals with its comprehensive experience and technologies in the spirit of animal welfare. Based on its experience acknowledged by pharmaceutical companies, CLEA Japan, Inc. efficiently provides CRO services to Physiogenex.

Since 2016, CLEA Japan Inc. has worked closely with Physiogenex in the development of the SDT fatty rat as a model of Type 2 diabetic nephropathy, retinopathy and cardiometabolic complications. This collaborative work has been presented in several international meetings such as the ASN Kidney Week, the Internal Society of Nephrology and the Association for Research in Vision and Ophthalmology (ARVO).

Visit the CLEA website for more information.

Central Lab. Animal Inc.

Central Lab. Animal Inc. is an expert supplier of experimental rodents, constantly providing best quality bioservices to researchers. Based on its experience acknowledged by pharmaceutical companies, Central Lab. Animal Inc. efficiently provides CRO services to Physiogenex.

Visit the Central Lab. Animal Inc. website for more information.

Aiosyn

Aiosyn is a pioneering medical software company that develops precision pathology software for cancer and kidney disease.

Aiosyn’s solutions are integrated into standard pathology workflows, improving clinical decision-making and accelerating drug development. The Aiosyn team has been built upon over 20 years of research experience in the field of pathology and is rooted in the pathology practice.

Visit Aiosyn for more information.